The mechanism is reasonable, the marketing is enthusiastic, the trials are largely absent
Improve Gut Health Your gut houses trillions of microbes that signal GLP-1 release
PKF275-055, an analog of vildagliptin, is a novel, selective, orally bioavailable, and long-acting DPP-4 inhibitor that has shown promising benefits in the prevention, protection, and treatment of diabetic neuropathy
Three phase I clinical trials conducted by dermatology clinics at the Arizona Health Sciences Center have investigated two dose levels of melanotan I combined with small doses of UV-B to the neck or buttock, or full sunlight to half of the back
The effects of castration on advanced carcinoma of the prostate